Multiplex Ligation Probe Amplification

Back to Tests

MLPA (Multiplex Ligation-dependent Probe Amplification) is a diagnostic technique used for the molecular analysis of copy number variations (CNVs) in the genome. This assay makes the use of probes specific to selective genes in order to reliably diagnose genetic disorders resulting from deletions or duplications in said genes.

Tests Offered

DMD By MLPA

  • Duchene Muscular Dystrophy
TAT: 15 Working Days

SMA By MLPA

  • Spinal Muscular Atrophy
TAT: 15 Working Days

Atypical HUS ((CFHR3/CFHR1/ CFH/ CFH2/ CFH4) By MLPA

  • Atypical Hemolytic Uremic Syndrome
TAT: 15 Working Days

FBN1 By MLPA

  • Marfan Syndrome
TAT: 21 Working Days

PMP22 By MLPA

  • Charcot-Marie-Tooth (CMT) Hereditary Neuropathy
TAT: 21 Working Days

BRCA1/2 By MLPA

  • Hereditary Breast and Ovarian Cancer (HBOC)
TAT: 21 Working Days

Note:

Test Requisition Form (TRF)

I Am Interested To Know More Details

Enquire Now

Accreditations

The above accreditations have been granted to NEUBERG SUPRATECH REFERENCE LABORATORIES PRIVATE LIMITED (NSRL). The Neuberg Center for Genomic Medicine (NCGM) is affiliated to NSRL.